Cue Biopharma files pre-funded warrant to purchase common stock

The company filed a pre-funded warrant granting the holder the right to purchase common stock at a price of $0.001 per share in 2026. This commercial document typically accompanies a private placement and includes standard regulatory transfer restrictions.